![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Zydus Lifesciences Limited Vadodara In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Atorvastatin calcium, Process II, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2011-156 - Rev 05
This Chemical Type CEP, issued on July 27, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2191 associated with this CEP further emphasizes